|
1
|
Ediger D, Sin BA, Heper A, Anadolu Y and
Misirligil Z: Airway inflammation in nasal polyposis:
immunopathological aspects of relation to asthma. Clin Exp Allergy.
35:319–326. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hedman J, Kaprio J, Poussa T and Nieminen
MM: Prevalence of asthma, aspirin intolerance, nasal polyposis and
chronic obstructive pulmonary disease in a population-based study.
Int J Epidemiol. 28:717–722. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Munoz del Castillo F, Jurado-Ramos A,
Fernandez-Conde BL, et al: Allergenic profile of nasal polyposis. J
Investig Allergol Clin Immunol. 19:110–116. 2009.
|
|
4
|
Asero R and Bottazzi G: Hypersensitivity
to molds in patients with nasal polyposis: a clinical study. J
Allergy Clin Immunol. 105:186–188. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Molnar-Gabor E, Endreffy E and Rozsasi A:
HLA-DRB1, -DQA1, and -DQB1 genotypes in patients with nasal
polyposis. Laryngoscope. 110:422–425. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pang YT, Eskici O and Wilson JA: Nasal
polyposis: role of subclinical delayed food hypersensitivity.
Otolaryngol Head Neck Surg. 122:298–301. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bronson PG, Caillier S, Ramsay PP, et al:
CIITA variation in the presence of HLA-DRB1*1501 increases risk for
multiple sclerosis. Hum Mol Genet. 19:2331–2340. 2010.
|
|
8
|
LeibundGut-Landmann S, Waldburger JM,
Krawczyk M, et al: Mini-review: specificity and expression of
CIITA, the master regulator of MHC class II genes. Eur J Immunol.
34:1513–1525. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Harton JA and Ting JP: Class II
transactivator: mastering the art of major histocompatibility
complex expression. Mol Cell Biol. 20:6185–6194. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhu XS, Linhoff MW, Li G, Chin KC, Maity
SN and Ting JP: Transcriptional scaffold: CIITA interacts with
NF-Y, RFX, and CREB to cause stereospecific regulation of the class
II major histocompatibility complex promoter. Mol Cell Biol.
20:6051–6061. 2000. View Article : Google Scholar
|
|
11
|
Mumtaz M, Lofgren S, Hugander A and
Dimberg J: Polymorphism in MHC class II transactivator gene is not
associated with susceptibility to colorectal cancer in Swedish
patients. Anticancer Res. 28:1789–1791. 2008.PubMed/NCBI
|
|
12
|
Wang D, Levasseur-Acker GM, Jankowski R,
et al: HLA class II antigens and T lymphocytes in human nasal
epithelial cells. Modulation of the HLA class II gene transcripts
by gamma interferon. Clin Exp Allergy. 27:306–314. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Koizumi K, Okamoto H, Iikuni N, et al:
Single nucleotide polymorphisms in the gene encoding the major
histocompatibility complex class II transactivator (CIITA) in
systemic lupus erythematosus. Ann Rheum Dis. 64:947–950. 2005.
View Article : Google Scholar
|
|
14
|
Skinningsrud B, Husebye ES, Pearce SH, et
al: Polymorphisms in CLEC16A and CIITA at 16p13 are associated with
primary adrenal insufficiency. J Clin Endocrinol Metab.
93:3310–3317. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pasaje CF, Bae JS, Park BL, et al:
Association analysis of DTD1 gene variations with
aspirin-intolerance in asthmatics. Int J Mol Med. 28:129–137.
2011.PubMed/NCBI
|
|
16
|
Menashe I, Rosenberg PS and Chen BE: PGA:
power calculator for case-control genetic association analyses. BMC
Genet. 9:362008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nyholt DR: A simple correction for
multiple testing for single-nucleotide polymorphisms in linkage
disequilibrium with each other. Am J Hum Genet. 74:765–769. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kramer MF and Rasp G: Nasal polyposis:
eosinophils and interleukin-5. Allergy. 54:669–680. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Karjalainen J, Joki-Erkkila VP, Hulkkonen
J, et al: The IL1A genotype is associated with nasal polyposis in
asthmatic adults. Allergy. 58:393–396. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Erbek SS, Yurtcu E, Erbek S, Atac FB,
Sahin FI and Cakmak O: Proinflammatory cytokine single nucleotide
polymorphisms in nasal polyposis. Arch Otolaryngol Head Neck Surg.
133:705–709. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang LF, Chien CY, Tai CF, Kuo WR, Hsi E
and Juo SH: Matrix metalloproteinase-9 gene polymorphisms in nasal
polyposis. BMC Med Genet. 11:852010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Erbek SS, Yurtcu E, Erbek S and Sahin FI:
Matrix metalloproteinase-9 promoter gene polymorphism (−1562C>T)
in nasal polyposis. Am J Rhinol Allergy. 23:568–570. 2009.
|
|
23
|
Arbag H, Cora T, Acar H, Ozturk K, Sari F
and Ulusoy B: Lack of association between the
glutathione-s-transferase genes (GSTT1 and GSTM1) and nasal
polyposis. Rhinology. 44:14–18. 2006.PubMed/NCBI
|
|
24
|
Bernstein JM, Anon JB, Rontal M, Conroy J,
Wang C and Sucheston L: Genetic polymorphisms in chronic
hyperplastic sinusitis with nasal polyposis. Laryngoscope.
119:1258–1264. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mfuna Endam L, Cormier C, Bosse Y,
Filali-Mouhim A and Desrosiers M: Association of IL1A, IL1B, and
TNF gene polymorphisms with chronic rhinosinusitis with and without
nasal polyposis: A replication study. Arch Otolaryngol Head Neck
Surg. 136:187–192. 2010.PubMed/NCBI
|
|
26
|
Pascual M, Sanz C, Isidoro-Garcia M, et
al: (CCTTT)n polymorphism of NOS2A in nasal polyposis and asthma: a
case-control study. J Investig Allergol Clin Immunol. 18:239–244.
2008.PubMed/NCBI
|
|
27
|
Mach B, Steimle V, Martinez-Soria E and
Reith W: Regulation of MHC class II genes: lessons from a disease.
Annu Rev Immunol. 14:301–331. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Otten LA, Steimle V, Bontron S and Mach B:
Quantitative control of MHC class II expression by the
transactivator CIITA. Eur J Immunol. 28:473–478. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
He Y, Zhao Y, Zhang S, et al: Not
polymorphism but methylation of class II transactivator gene
promoter IV associated with persistent HBV infection. J Clin Virol.
37:282–286. 2006. View Article : Google Scholar : PubMed/NCBI
|
